• Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Kun Wha Pharmaceutical Co Ltd

+ Add to Watchlist

002250:KS

12,400 KRW 100 0.80%

As of 01:06:17 ET on 01/27/2015.

Snapshot for Kun Wha Pharmaceutical Co Ltd (002250)

Open: 12,400 Day's Range: 12,350 - 12,600 Volume: 13,341
Previous Close: 12,500 52wk Range: 12,100 - 25,500 1-Yr Rtn: -33.15%

Stock Chart for 002250

No chart data available.
  • 002250:KS 12,400
  • 1D
  • 1M
  • 1Y
12,500
Interactive 002250 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002250

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. KOSPI -
Earnings Per Share (ttm) -1,158.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M KRW) 147,038.23
Shares Outstanding (M) 11.86
30 Day Average Volume 44,000
Price/Book (mrq) 0.6554
Price/Sale (ttm) 0.8969
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002250

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 002250

Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.

Lee Joo-HyungCEO/Rep DirectorKim Dae-HwanSenior Managing Director
Lee Bok-SangSenior Managing DirectorKim Choong-RyulSenior Managing Director
More Company Profile & Key Executives for 002250

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil